Pfizer said it expected to apply in November for US authorisation of its Covid-19 vaccine for children aged between six months and five-years-old as it races to expand eligibility for the jab.
辉瑞(Pfizer)表示，预计将于11月在美国申请将其新冠疫苗用于6个月至5岁儿童的授权。目前，该公司正在加紧扩大其疫苗的合格使用范围。
您已阅读8%（260字），剩余92%（3113字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。